Promising Outcomes in Acromegaly Patients Receiving CyberKnife Stereotactic Hypofractionated Radiotherapy

Background: The primary treatment for patients with acromegaly has traditionally been transsphenoidal surgery, with decreasing reliance on radiotherapy (RT) due to advancements in pharmacotherapy (PT). Despite these advancements, a substantial portion of patients still face persistent acromegaly, ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Meral, Rasim, Selcukbiricik, Ozlem S, Uzum, Ayse K, Sahin, Serdar, Okutan, Murat, Barburoglu, Mehmet, Dolas, Ilyas, Altun, Musa, Yarman, Sema, Kadıoglu, Pinar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613787/
https://www.ncbi.nlm.nih.gov/pubmed/37908695
http://dx.doi.org/10.7759/cureus.47936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613787/
https://www.ncbi.nlm.nih.gov/pubmed/37908695
http://dx.doi.org/10.7759/cureus.47936

Ejemplares similares